Helmholtz Munich

The host of this seminar is Ari Melnick.

Daniel Krappmann is the Director of the Research Unit ‘Signalling and Translation’ at the Molecular Targets and Therapeutics Center of Helmholtz Munich. He is Professor at the Biology Faculty of the Ludwig-Maximilians-University in Munich. As PhD student, postdoctoral fellow and junior group leader at the Max-Delbrück-Center for Molecular Medicine in Berlin, he worked on signalling mechanisms in cancer and immune cells. His Research Unit at Helmholtz Munich studies how physiological signaling networks control immune homeostasis and activation and how defective or aberrant signaling leads to immune diseases and cancer. His studies aim to bridge the gap between biomedical research and clinical translation. He has been leading successful drug discovery programmes and is involved in the pre-clinical development of anti-cancer therapeutics and new immune modulatory agents.

IJC Auditorium + Online
Inscripción